The International Society of Oncology and Biomarkers (ISOBM) was founded in the early 1970s. The society was originally known as the International Society of Oncodevelopmental Biology and Medicine” (ISOBM) as the main interest of the founding members was in exploiting proteins involved in embryonic development as tumor markers. In 2010, the name of the Society was changed to the International Society of Oncology and Biomarkers (also known as ISOBM). This change in name reflected the then broader interests of the society members, especially in the areas of Cancer Biomarkers, Tumor Biology and novel Cancer therapeutics. Currently, the ISOBM is one of premier international organizations with a broad interest in Tumor Biomarkers.
ISOBM is a registered UK Non Profit organization, registration number 469359.
Official Postal adrress
ISOBM C/o Dr. Catharine M. Sturgeon Dept Clinical Biochemistry Edinburgh Royal Infirmary Edinburgh EH16 4SA Scotland
The society organizes annual or biannual meetings. These meetings focus mostly on Cancer Biomarkers, Tumor Biology and novel Cancer therapeutics. ISOBM also organizes a series of Antibody Workshops which provide a practical focus on Tumor Markers in different types of Cancer. More information on this resource is available on the ISOBM website. The official journal of the society is Tumor Biology.
The ISOBM is an international society devoted to bridging the gap between basic science and clinical application. As such the ISOBM provides a unique forum for discussion and development of novel approaches to clinical problems in cancer. As a society we aim to support good communication between scientific interests, clinicians and commercial groups during our annual meetings and through the ISOBM Antibody Workshops system.